multi source·2h ago·4 sources analyzed
Trump Signs Executive Order on Psychedelic Drug Review
The executive order aims to expedite the review process for certain psychedelic substances. The directive specifically targets drugs designated as breakthrough therapies. (sources: aljazeera, nbcnews, foxnews, cspan)
Image: cspan
ModernAction Briefing
Trump signed an executive order directing the FDA to review psychedelics, including ibogaine, for potential therapeutic use. The order seeks to relax federal restrictions on these substances.
- The executive order calls for the FDA to expedite the review of psychedelics classified as breakthrough therapy drugs.
- Trump made a joke about ibogaine during the signing event.
- Joe Rogan was present during the signing of the executive order.
Why it matters
The order could lead to increased research and potential therapeutic applications for psychedelics in medical treatment.
No specific legislation identified for action yet.
Top coverage · 4 sources
aljazeeraTrump joined by Joe Rogan as he signs order to speed up psychedelic reviewnbcnewsTrump jokes about asking for ibogaine at executive order signingfoxnewsTrump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugscspanPresident Trump Signs Executive Order